Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 2/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2747230 | 0.94 | CA1 (0.32) | CA1MEN1ALDH1A1TSHRKMT2A | |
| Zinc Ion SCHEMBL565411 | 0.94 | CA1 (0.32) | CA1MEN1ALDH1A1TSHRKMT2A | |
| SCHEMBL8496876 | 0.94 | CA1 (0.32) | CA1MEN1ALDH1A1TSHRKMT2A | |
| SCHEMBL8408481 | 0.94 | CA1 (0.32) | CA1MEN1ALDH1A1TSHRKMT2A | |
| SCHEMBL21814097 | 0.94 | CA1 (0.32) | CA1MEN1ALDH1A1TSHRKMT2A | |
| SCHEMBL525440 | 0.94 | CA1 (0.32) | CA1MEN1ALDH1A1TSHRKMT2A | |
| SCHEMBL526841 | 0.69 | CA5A (0.31) | — | |
| SCHEMBL27998785 | 0.69 | TSSK1B (0.43) | CA1MEN1ALDH1A1TSHRKMT2A | |
| Sulfuric Acid SCHEMBL1003195 | 0.67 | CA1 (0.61) | CA1MEN1ALDH1A1TSHRKMT2A | |
| Sulfuric Acid SCHEMBL28130838 | 0.67 | FFAR3 (0.54) | CA1MEN1ALDH1A1TSHRKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 62 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2332583-B1 | ANTIVIRAL DISINFECTANTS AND THEIR APPLICATIONS | GOJO IND INC (US) | 2018-12-19 | — | — | EP | claimed |
| US-20130237598-A1 | ANTIVIRAL COMPOSITIONS | GOJO INDUSTRIES, INC. (US) | 2013-09-12 | — | — | US | claimed |
| US-8450378-B2 | Antiviral method | GOJO INDUSTRIES, INC. (US) | 2013-05-28 | — | — | US | claimed |
| EP-2332583-A1 | Antiviral disinfectants and their applications | Gojo Industries, Inc. (US) | 2011-06-15 | — | — | EP | claimed |
| US-20090018213-A1 | ANTIVIRAL METHOD | SILVER POINT FINANCE, LLC, AS COLLATERAL AGENT | 2009-01-15 | — | — | US | claimed |
| US-5925366-A | PERMEATION/BINDING AGENT, THIO CROSSLINKING AGENT, AND CHELATE COMPOUND | REVLON CONSUMER PRODUCTS CORPORATION (US) | 1999-07-20 | — | — | US | claimed |
| US-5785959-A | MIXTURE CONTAINING A PERMEATION/BINDING AGENT, A THIO CROSSLINKING AGENT, A CHELATING AGENT, WATER AND AN OIL | REVLON CONSUMER PRODUCTS CORPORATION (US) | 1998-07-28 | — | — | US | claimed |
| WO-1998006376-A1 | NAIL STRENGTHENING COMPOSITIONS AND A METHOD FOR STRENGTHENING NAILS | REVLON CONSUMER PRODUCTS CORPORATION (US) | 1998-02-19 | — | — | WO | claimed |
| US-20260102355-A1 | ORAL PREPARATION COMPRISING CHICORY DIETARY FIBER OR CASSAVA STARCH | LG H&H CO., LTD. (KR) | 2026-04-16 | — | — | US | disclosed |
| US-20250340743-A1 | Polyetheramine-Based Multifunctional Booster | TROY TECH II INC (US) | 2025-11-06 | — | — | US | disclosed |
| US-20250154197-A1 | LIPOLYTIC PEPTIDES | FUNDACIÓ HOSPITAL UNIVERSITARI VALL D'HEBRON - INSTITUT DE RECERCA (ES) | 2025-05-15 | — | — | US | disclosed |
| EP-4535999-A1 | POLYETHERAMINE-BASED MULTIFUNCTIONAL BOOSTER COMPOSITIONS | Troy Technology II, Inc. (US) | 2025-04-16 | — | — | EP | disclosed |
| CN-113453675-B | Use of caprylic acid and capric acid triglycerides for the treatment of diseases or disorders mediated by silk fibroin or collagen deficiency | 医姿挺有限公司 | 2025-03-14 | — | — | CN | disclosed |
| US-12144794-B2 | Use of caprylic and capric triglycerides for the treatment of a disease or condition mediated by filaggrin or collagen deficiency | ISDIN, S.A. (ES) | 2024-11-19 | — | — | US | disclosed |
| EP-2012838-A2 | ANTIVIRAL DISINFECTANTS AND APPLICATIONS | Gojo Industries, Inc. (US) | 2009-01-14 | — | — | EP | disclosed |
| WO-2007095008-A2 | ANTIVIRAL DISINFECTANTS AND APPLICATIONS | GOJO INDUSTRIES, INC. (US) | 2007-08-23 | — | — | WO | disclosed |
| US-20070185216-A1 | ANTIVIRAL METHOD | PNC BANK, NATIONAL ASSOCIATION, AS AGENT | 2007-08-09 | — | — | US | disclosed |
| US-5925366-A | PERMEATION/BINDING AGENT, THIO CROSSLINKING AGENT, AND CHELATE COMPOUND | REVLON CONSUMER PRODUCTS CORPORATION (US) | 1999-07-20 | — | — | US | disclosed |
| US-5785959-A | MIXTURE CONTAINING A PERMEATION/BINDING AGENT, A THIO CROSSLINKING AGENT, A CHELATING AGENT, WATER AND AN OIL | REVLON CONSUMER PRODUCTS CORPORATION (US) | 1998-07-28 | — | — | US | disclosed |
| WO-1998006376-A1 | NAIL STRENGTHENING COMPOSITIONS AND A METHOD FOR STRENGTHENING NAILS | REVLON CONSUMER PRODUCTS CORPORATION (US) | 1998-02-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260102355-A1 | ORAL PREPARATION COMPRISING CHICORY DIETARY FIBER OR CASSAVA STARCH | SI, TAS2R41, TAS2R14 | CA1 1965/4885MEN1 4702/4885ALDH1A1 3261/4885 |
| US-12144794-B2 | Use of caprylic and capric triglycerides for the treatment of a disease or condition mediated by filaggrin or collagen deficiency | CAPRIN1, MTTP, APOB | CA1 3370/4885MEN1 1623/4885ALDH1A1 2742/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.